School of Medicine
Showing 1-10 of 17 Results
-
Adrian Valladarez
Clinical Research Coordinator Associate, Neurology Research
Current Role at StanfordClinical Research Coordinator Associate
-
Keith Van Haren, MD
Associate Professor of Neurology and Neurological Sciences (Pediatric Neurology) and of Pediatrics
Current Research and Scholarly InterestsOur research team is working to develop new treatments for children at risk of neurodegenerative diseases. We are primarily focused on multiple sclerosis and X-linked adrenoleukodystrophy, two conditions that involve inflammatory and metabolic disruption of the myelin that insulates brain cells. A key area of interest for us is how nutrient deficiencies during childhood may contribute to the disease processes and whether nutritional interventions could play a role in prevention.
-
Kelly Vanden
Research Assistant, Adult Neurology
Current Role at StanfordAs a Laboratory Research Technician in Dr. Marion Buckwalter's Laboratory, Kelly conducts research that explores inflammatory responses after brain injury affect neurological recovery. Kelly works directly with Dr. Elizabeth Mayne in her exploration of long term adolescent recovery after stroke.
-
Gil Vantomme
Postdoctoral Scholar, Neurology and Neurological Sciences
BioGil Vantomme, PhD
Postdoctoral Fellow, Stanford University
Dr. Vantomme is a neuroscientist specializing in electrophysiology and neural circuit dynamics. His research focuses on understanding the role of thalamocortical networks in cognition and neurological disorders, including epilepsy and autism spectrum disorders. Leveraging innovative in vitro and in vivo electrophysiological assays, Dr. Vantomme investigates the mechanisms underlying cognitive deficits and explores novel therapeutic strategies, including drug development and neuromodulation. -
Aditya Vaze
Affiliate, Neurology & Neurological Sciences
BioDr. Vaze is a board-certified, fellowship-trained cardiologist with Stanford Medicine Partners Cardiology Castro Valley, Stanford Health Care Emeryville, and Heart & Vascular Clinic Pleasanton. He holds board certifications in cardiovascular disease, adult echocardiography, cardiac CT, nuclear cardiology, and internal medicine.
Dr. Vaze prides himself on providing comprehensive, patient-focused care and acting as a partner in navigating the complexities of a heart condition diagnosis. He focuses on evidence-based medicine, the latest diagnostic tools and testing, and most of all, his patients’ needs. Dr. Vaze wants his patients to actively participate in their care, as he believes it leads to the best outcomes and to more personalized care.
Dr. Vaze has a strong interest in improving quality and business processes to deliver efficient, streamlined care. He has worked on interventions for increasing safety and satisfaction across multiple hospital systems, including leading local projects focused on optimizing coronary angiography patient workflows. Dr. Vaze has also participated in national projects including the Million Hearts® Cardiovascular Disease Risk Reduction Model to reduce cardiovascular disease risk.
Dr. Vaze’s clinical research interests include atrial fibrillation and predicting cardiac mortality. Dr. Vaze has published his work in many peer-reviewed journals, including PLOS One, Clinical Cardiology, Journal of the American College of Cardiology, and Current Cardiology Reports. He has also coauthored many abstracts for the American Heart Association Scientific Sessions.
Dr. Vaze is a member of the American College of Cardiology, the American Heart Association, the American Society of Echocardiography, and the American Society of Nuclear Cardiology. -
Chitra Venkatasubramanian, MBBS, MD, MSc, FNCS
Clinical Professor, Adult Neurology
Clinical Professor (By courtesy), NeurosurgeryCurrent Research and Scholarly InterestsI am interested in the study of the radiological characteristics and temporal profile of edema/ tissue injury in the perihematomal area around spontaneous intracerebral hemorrhage. I am also interested in developing protocols for emergent reversal of anticoagulation in a life-threatening hemorrhage situation.
